Agile Therapeutics, Inc.
AGRXNASDAQHealthcare
$1.51
+$0.05(+3.42%)
Market Cap$10425795
P/E Ratio—
52W High$2.63
52W Low$0.2
Agile Therapeutics, Inc.（AGRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AGRX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $19.59M | $10.88M | $4.10M | $0.75M | $0.00M |
| Cost of Revenue | $8.98M | $6.84M | $10.72M | $0.28M | $0.16M |
| Gross Profit | $10.62M | $4.05M | ($6.62M) | $0.47M | ($0.16M) |
| Gross Margin %(computed) | 54.18% | 37.19% | -161.35% | 62.35% | — |
| Operating Expenses | |||||
| R&D Expenses | $2.23M | $3.25M | $6.25M | $13.50M | $9.86M |
| G&A Expenses | $10.51M | $11.86M | $14.70M | $12.73M | $9.00M |
| Total Operating Expenses | $30.50M | $45.48M | $64.39M | $49.52M | $18.86M |
| Operating Income | ($19.88M) | ($41.43M) | ($71.00M) | ($49.05M) | ($18.86M) |
| Operating Margin %(computed) | -101.49% | -380.69% | — | — | — |
| Interest Income | $0.08M | $0.08M | $0.03M | $0.31M | $0.25M |
| Interest Expense | $1.42M | $3.13M | $3.91M | $3.11M | $0.00M |
| Income Before Tax | ($14.46M) | ($30.09M) | ($74.89M) | ($51.85M) | ($18.61M) |
| Income Tax Expense | $0.00M | ($4.67M) | $1.69M | $0.00M | ($0.16M) |
| Net Income | ($14.46M) | ($25.41M) | ($76.58M) | ($54.69M) | ($18.44M) |
| Net Margin %(computed) | -73.83% | -233.48% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-6.71 | $-58.79 | $-63115.49 | $-1291.56 | $-746.20 |
| Wtd Avg Shares | 2.16M | 0.43M | 0.00M | 0.04M | 0.02M |
| EBITDA | ($12.66M) | ($25.42M) | ($64.93M) | ($48.47M) | ($18.61M) |
| EBITDA Margin %(computed) | -64.61% | -233.57% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Agile Therapeutics, Inc.
关于Agile Therapeutics, Inc.（AGRX）损益表
Agile Therapeutics, Inc.（AGRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年，AGRX实现营收$0.02B，毛利润$0.01B（毛利率54.18%），净利润($0.01B)（净利率-73.83%）。
常见问题
AGRX · 4 问Agile Therapeutics, Inc.（AGRX）2023财年营收为$0.02B，同比up80.0%。
AGRX revenueAGRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09